The Food and Drug Administration, making good on a Trump administration promise to examine the usage of antidepressants, on July 21 convened a panel largely of antidepressant skeptics to discuss the health impacts of taking such medicine while pregnant, though several panelists have no particular expertise on pregnancy research.
This article was originally published on MedicalXpress.com